Trial Profile
Retrospective analysis of Tofacitinib with and without Methotrexate from the Rhumadata Clinical Database and Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2020
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Abatacept; Methotrexate; Rituximab; Sarilumab; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2020 Results (n=194) evaluating the efficacy and retention rate of Tofacitinib Monotherapy or Combined with Methotrexate in Patients with Rheumatoid Arthritis, presented at the 21st Annual Congress of the European League Against Rheumatism
- 15 Jun 2019 Results (n=480) presented at the 20th Annual Congress of the European League Against Rheumatism
- 15 Jun 2019 Results (n=483) presented at the 20th Annual Congress of the European League Against Rheumatism